ZARVY

Voglitab 0.2 is a generic medication containing Voglibose 0.2mg, an alpha-glucosidase inhibitor widely used for the management of Type 2 diabetes mellitus. It works by slowing down the digestion and absorption of carbohydrates, helping to control postprandial blood sugar levels and prevent sudden glucose spikes after meals. By targeting the enzyme alpha-glucosidase in the small intestine, Voglibose ensures that glucose is absorbed gradually, providing better glycemic control. This medication is particularly beneficial for individuals who struggle with post-meal hyperglycemia, making it an essential part of comprehensive diabetes treatment. In addition to its blood sugar-regulating properties, Voglibose may contribute to weight management by preventing rapid insulin fluctuations, which are linked to fat accumulation.